1. Appelbaum PC, Spangler SK, Potter CR, et al (1986) Reduction of oral flora with rifampin in healthy volunteers. Antimicrob Agents Chemother 29:576-578

2. Arditi M, Yogev R (1989) In vitro interaction between rifampin and clindamycin against pathogenic co-agulase-negative staphylococci. Antimicrob Agents Chemother 33:245-247

3. Banerjee AK (1992) Surgical treatment of hidradeni-tis suppurativa. Br J Surg 79:863-866

4. Baron EJ, Curren M, Henderson G, et al (1992) Bi-lophila wadsworthia isolates from clinical specimens. J Clin Microbiol 30:1882-1884

5. Bendahan J, Paran H, Kolman S, et al (1992) The possible role of Chlamydia trachomatis in perineal suppurative hidradenitis. Eur J Surg 158:213-215

6. Boer J, Weltevreden EF (1996) Hidradenitis suppu-rativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol 135:721-725

7. Brenner DE, Lookingbill DP (1980) Anaerobic microorganisms in chronic suppurative hidradenitis. Lancet 2:921-922

8. Brook I, Frazier EH (1999) Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol 48:103-105

9. Brunsting HA (1939) Hidradenitis suppurativa; abscess of the apocrine sweat glands. Arch Dermatol Syphilol 39:108-120

10. Buckley C, Sarkany I (1989) Urethral fistula and sinus formation in hidradenitis suppurativa. Clin Exp Dermatol 14:158-160

11. Burkhart CN, Burkhart CG (2003) Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int J Dermatol 42:925-927

12. Clemmensen OJ (1983) Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 22:325-328

13. Dicken CH, Powell ST, Spear KL (1984) Evaluation of isotretinoin treatment of hidradenitis suppura-tiva. J Am Acad Dermatol 11:500-502

14. Dougherty SH (1988) Pathobiology of infection in prosthetic devices. Rev Infect Dis 10:1102-1117

15. Dreno B (2004) Topical antibacterial therapy for acne vulgaris. Drugs 64:2389-2397

16. Eady EA, Holland KT, Cunliffe WJ (1982) The use of antibiotics in acne therapy: oral or topical administration? J Antimicrob Chemother 10:89-115

17. Editorial (1985) Streptococcus milleri, pathogen in various guises. Lancet 2:1403-1404

18. Finegold S, Summanen P, Hunt Gerardo S, et al (1992) Clinical importance of Bilophila wadswor-thia. Eur J Clin Microbiol Infect Dis 11:1058-1063

19. Goodheart HP (2000) Hidradenitis suppurativa. Dermatology Rounds 3:535-543

20. Granato P (2003) Pathogenic and indigenous microorganisms of humans. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. ASM, Washington DC

21. Hay RJ, Adriaans BM (2004) Bacterial infections. In: Burns T, Breathnach S, Cox N, Griffiths C (eds) Rook's textbook of dermatology. Blackwell Science, Oxford

22. Hedstrom SA (1982) Recurrent anaerobic skin abscesses. Scand J Infect Dis 14:241-242

23. Highet AS, Warren RE, Staughton RC, et al (1980) Streptococcus milleri causing treatable infection in perineal hidradenitis suppurativa. Br J Dermatol 103:375-382

24. Highet AS, Warren RE, Weekes AJ (1988) Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol 124:1047-1051

25. Hindle EAO, Kirby B, Griffiths CEM (2002) Hi-dradenitis suppurativa and acne keloidalis nuchae treated with clindamycin and rifampicin: a case series. Br J Dermatol 147:22-23

26. Holland KT, Holland DB, Cunliffe WJ, et al (1993) Detection of Propionibacterium acnes polypeptides which have stimulated an immune response in acne patients but not in normal individuals. Exp Dermatol 2:12-16

27. Jansen I, Altmeyer P, Piewig G (2001) Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol 15:532-540

28. Jansen T, Plewig G (2000) What's new in acne inversa (alias hidradenitis suppurativa)? J Eur Acad Dermatol Venereol 14:342-343

29. Jemec GB, Faber M, Gutschik E, et al (1996) The bacteriology of hidradenitis suppurativa. Dermatology 193:203-206

30. Jemec GB, Wendelboe P (1998) Topical clindamy-cin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39:971-974

31. Jovanovic M (2004) Hidradenitis suppurativa

32. Kloos W (1986) Ecology of human skin. Almqvist and Wiksell, Stockholm

33. Lapins J, Jarstrand C, Emtestam L (1999) Coagu-lase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 140:9095

34. Lapins J (2001) Hidradenitis suppurativa with special reference to carbon dioxide laser surgery. Aka-demitryck, Stockholm

35. Leach RD, Eykyn SJ, Phillips I, et al (1979) Anaerobic axillary abscess. Br Med J 2:5-7

36. Molnar C, Hevessy Z, Rozgonyi F, et al (1994) Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydropho-bicity, and toxin production in vitro. J Clin Pathol 47:743-748

37. Mowad CM, McGinley KJ, Foglia A, et al (1995) The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 33:729-733

38. Noble WC (1990) Factors controlling the microflora of the skin. In: Hill MJ, Marsh PD (eds) Human mi-crobial ecology. CRC, Boca Raton, Fla.

39. Nord CE, Heimdahl A, Kager L (1986) Antimicrobial induced alterations of the human oropharyn-geal and intestinal microflora. Scand J Infect Dis Suppl 49:64-72

40. Oldfield EC 3rd (2004) Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. Rev Gastroenterol Disord 4:186-195

41. O'Loughlin S, Woods R, Kirke PN, et al (1988) Hi-dradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients. Arch Dermatol 124:1043-1046

42. Otto M (2004) Virulence factors of the coagulase-negative staphylococci. Front Biosci 9:841-863

43. Pasquale TR, Tan JS (2005) Nonantimicrobial effects of antibacterial agents. Clin Infect Dis 40:127135

44. Pawin H, Beylot C, Chivot M, et al (2004) Physio-pathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 14:4-12

45. Powell JJ, Dawber RP, Gatter K (1999) Folliculitis decalvans including tufted folliculitis: clinical, his-tological and therapeutic findings. Br J Dermatol 140:328-333

46. Raad II, Bodey GP (1992) Infectious complications of indwelling vascular catheters. Clin Infect Dis 15:197-208

47. Roth RR, James WD (1988) Microbial ecology of the skin. Annu Rev Microbiol 42:441-464

48. Sellheyer K, Krahl D (2004) "Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol doi:10.1111/j.1365-4632.2004.02536.x

49. Shelley WB, Cahn MM (1955) The pathogenesis of hidradenitis suppurativa in man; experimental and histologic observations. AMA Arch Derm 72:562565

50. Slade DE, Powell BW, Mortimer PS (2003) Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56:451-461

51. Spizek J, Novotna J, Rezanka T (2004) Lincos-amides: chemical structure, biosynthesis, mechanism of action, resistance, and applications. Adv Appl Microbiol 56:121-154

52. Spizek J, Rezanka T (2004) Lincomycin, clindamy-cin and their applications. Appl Microbiol Biotech-nol 64:455-464

53. Sullivan A, Edlund C, Nord CE (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1:101-114

54. Till AE, Layton AM, Barth JH (1995) Staphylococcus lugdunensis isolated from axillary apocrine glands of hidradenitis suppurativa patients. J Invest Dermatol 104:618

55. Tsankov N, Angelova I (2003) Rifampin in dermatology. Clin Dermatol 21:50-55

56. Vandenesch F, Eykyn SJ, Ettienne J (1995) Infections caused by newly-described species of coagulase negative staphylococci. Rev Med Microbiol 6:94-100

57. von der Werth JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14:389-392

Chapter 12



Michel Faure, Evelyne Drapier-Faure

Solve Your Acne Problems

Solve Your Acne Problems

Solve Your Acne Problems With These Simple Home Remedies.

Get My Free Ebook

Post a comment